• About
• Links
• Contact
• Sitemap

Gene Expression Reagents Markets

The area of gene expression reagents is one of the newest and most important sectors of pharmaceutical and bioscience research and development. The term gene expression reagents refers to chemicals that are used in gene expression experiments that are performed to determine whether a particular gene is expressed--i.e., present--and in some cases at what levels, in a biological sample.

The purpose of this TriMark Publications report is to describe the specific segments of the global gene expression reagents market. Within this area, the study covers those segments that are highly active in terms of innovation and growth. Specifically, this review examines the markets for gene expression reagents and small lab equipment all the way up to highly automated platforms. Emphasis is on those companies that are actively developing and marketing gene expression reagents for genomics research in the academic sector and the pharmaceutical, bioscience industry. This study concentrates on the laboratory reagent market segment and the companion gene expression reagents sector in the U.S. and around the world that use materials for genetic research. Particular attention is paid to those areas of the gene expression reagents sector that are showing the greatest growth or the most innovation.

The report attempts to answer the following questions:

• What companies are the key players?
• What is the market for gene express reagents?
• What are the opportunities in gene expression reagents markets?
• What are the developing trends?
• Where are the new market growth areas?
• What are the most favored technology platforms?
• Where are the gene expression reagent technologies taking researchers?
• How are gene expression reagent technologies blending with more established laboratory procedures?
• What are the business trends in the industry?

The study surveys some of the leading companies known to be marketing, manufacturing or developing products for the gene expression reagents market for those sectors covered here. Each company is discussed in depth with a section on the history of the company, the product line, business and marketing analysis, and a subjective commentary of the position of the company in its market.

The benefits of this report are:

• In-depth analysis of the major sectors of the gene expression reagent sectors, their size, growth rates and major drivers.
• Presentation of some of the emerging technology platforms, elucidating the potential areas that could gain traction in this market.
• Analysis of the partnerships and alliances the various key sector players have forged, as well as describing financings of these market participants, giving insight into potential market collaborations.
• Examination of new technology platforms that seek to dominate this new market, and to identify lead positions and potential future growth areas.
• An overview of the current state of gene expression assays used in drug development and the numerous opportunities that exist to increase the quality of genetic sequences evaluated.
• A profile of the gene expression customer and an analysis of factors influencing the adoption of specific gene exploration technology.
• A five-year projection of spending on new equipment and reagents.Impact of commercial gene reagents on genetic R&D.

Table of Contents

• 1.Overview5
  • 1.1Objectives of the Report5
  • 1.2Methodology6
  • 1.3Scope of the Report7
  • 1.4Executive Summary7
  
  
• 2.Gene Expression9
  • 2.1The Genomics Revolution9
  • 2.2Basic Principles of Gene Expression9
    • 2.3.1Quantitative Real-Time PCR (qRT-PCR)10
    • 2.3.2PCR Labeling Chemistries11
    • 2.3.3TaqMan® Probes11
    • 2.3.4SYBR® Green11
  • 2.4Microarray Technology12
  • 2.5Microarray Target Preparation and Hybridization12
  • 2.6RNA Sample Preparation and Assessment13
  
  
• 3.Gene Expression Reagents15
  • 3.1Kit Format vs. Home-Brew Assays15
  • 3.2Whole Product Solutions15
  • 3.3Emerging Technologies16
  
  
• 4.Market Environment17
  • 4.1Institutional and Government Budgeting17
  • 4.2Worldwide Investment in Genomics Technologies and Research17
  • 4.3Industry Consolidation and Acquisitions18
  
  
• 5.Market Drivers19
  • 5.1Improved Assay Performance19
  • 5.2Cost Effective Systems19
  • 5.3Automation21
  • 5.4Bioinformatics Solutions21
  
  
• 6.Worldwide Market for Gene Expression Reagents23
  • 6.1Life Science Research23
  • 6.2Drug Discovery and Development, Molecular Diagnostics23
  • 6.3Commercial Production23
  • 6.4Gene Expression Market Size23
    • 6.4.1Real-Time PCR Revenue25
    • 6.4.2Commercial Microarray Revenue25
    • 6.4.3RNA Sample Preparation Revenue26
  • 6.5Gene Expression Reagent Market by Region26
  • 6.6Users of Gene Expression Products27
    • 6.6.1Core Laboratories28
    • 6.6.2Consortia28
    • 6.6.3Pharmaceutical and Biotechnology Companies28
  • 6.7Affiliation28
  • 6.8Job Function and Decision Makers29
  
  
• 7.Key Applications32
  • 7.1BioMarker Identification and Pharmacogenomics32
  • 7.2Toxicogenomics32
  • 7.3Molecular Diagnostics32
  
  
• 8.Vendor and Product Selection33
  • 8.1Product Adoption33
  • 8.2Drivers for Product Switching34
  
  
• 9.Leading Vendors35


• 10.Marketing Strategies38
  • 10.1e-Marketing and e-Commerce38
  • 10.2Catalog38
  • 10.3On-Site Cabinet Programs39
  
  
• 11.Pricing Strategies40
  • 11.1Price Elasticity40
  • 11.2Strategies41
  
  
• 12.Distribution Channels43


• 13.Competitive Situation44


• 14.Opportunities47


• 15.Market Strategy Profiles, Leading and Selected Vendors48
  • 15.1Applied Biosystems48
    • 15.1.1Applera Corporation-Corporate History and Structure48
    • 15.1.2Molecular Biology Technology and Products49
    • 15.1.3Acquisitions, Partnerships and Collaborations, 200650
    • 15.1.4Product Portfolio Summary50
    • 15.1.5Real-Time PCR/Genomics Products and Consumables51
    • 15.1.6Real-Time PCR/Genomics New Product Introductions, 200651
    • 15.1.7End-Users51
    • 15.1.8Distribution Channels52
    • 15.1.9Competition-Gene Expression Products52
    • 15.1.10Competitive Analysis52
    • 15.1.11Business Model52
  • 15.2Affymetrix53
    • 15.2.1Corporate History and Structure53
    • 15.2.2Technology54
    • 15.2.3Partnerships and Collaborations54
    • 15.2.4Product Portfolio Summary55
    • 15.2.5Complementary Services56
    • 15.2.6New Product Introductions57
    • 15.2.7End-Users57
    • 15.2.8Distribution Channels57
    • 15.2.9Competition58
    • 15.2.10Competitive Analysis58
    • 15.2.11Business Model58
  • 15.3Invitrogen59
    • 15.3.1Corporate History and Structure59
    • 15.3.2Technology59
    • 15.3.3Acquisitions60
    • 15.3.4Partnerships and Collaborations61
    • 15.3.5Product Profile Summary61
    • 15.3.6Gene Expression Product Portfolio63
    • 15.3.7New Product Introductions64
    • 15.3.8End-Users64
    • 15.3.9Distribution Channels65
    • 15.3.10Competition65
    • 15.3.11Competitive Analysis65
    • 15.3.12Business Model65
  • 15.4Qiagen66
    • 15.4.1Corporate History and Structure66
    • 15.4.2Technology67
    • 15.4.3Acquisitions, Partnerships and Collaborations67
    • 15.4.4Collaborations and Partnerships68
    • 15.4.5Product Portfolio Summary68
    • 15.4.6Complementary Services69
    • 15.4.7New Product Introductions69
    • 15.4.8End-Users70
    • 15.4.9Distribution Channels70
    • 15.4.10Competition70
    • 15.4.11Competitive Analysis70
    • 15.4.12Business Model71
  • 15.5GE Healthcare (Formerly Amersham Biosciences)71
    • 15.5.1Corporate History and Structure71
    • 15.5.2Technology72
    • 15.5.3Product Portfolio Summary73
    • 15.5.4Complementary Services75
    • 15.5.5Genomics New Product Introductions75
    • 15.5.6Amersham Biosciences End-Users75
    • 15.5.7Distribution Channels75
    • 15.5.8Competition75
    • 15.5.9Competitive Analysis75
    • 15.5.10Business Model76
  • 15.6Stratagene76
    • 15.6.1Corporate History and Structure76
    • 15.6.2Technology77
    • 15.6.3Acquisitions, Collaborations, Alliances and Partnerships78
    • 15.6.4Product Portfolio Summary-Research Products Division78
    • 15.6.5New Product Introductions79
    • 15.6.6Complementary Services79
    • 15.6.7End-Users80
    • 15.6.8Distribution Channels80
    • 15.6.9Competition80
    • 15.6.10Competitive Analysis80
    • 15.6.11Business Model81
    
    

Appendix I: Leading Vendor's Gene Expression Products82

Appendix II: Gene Expression Product Groups92

Appendix III: Companies Offering Gene Expression Products93

LIST OF FIGURES

Figure 2.1: Gene Expression Process9

Figure 2.2: qRT-PCR Workflow11

Figure 2.3: Microarray Workflow13

Figure 6.1: Gene Expression Market by Region26

Figure 6.2: Researchers Using Gene Expression Technologies Worldwide, 200527

Figure 6.3: Distribution of Laboratory Workers by Organization in North America29

Figure 6.4: Laboratory Job Function29

Figure 6.5: Product Selection and Purchasing Decision Makers30

LIST OF TABLES

Table 5.1: Microarray Analysis Cost per Sample20

Table 5.2: Cost of qRT-PCR Research Reagents and Systems20

Table 6.1: Five-Year Forecast-Gene Expression Reagents, Instruments24

Table 6.2: RNA Sample Preparation Revenue24

Table 6.3: Forecasted Annual Revenue-qRT-PCR, 2005-201024

Table 6.4: Forecasted Annual Revenue-Commercial Microarrays, Reagents, Instruments, 2005-201024

Table 6.5: Forecasted Annual Revenue-Gene Expression Reagents, Instruments, 2005-201025

Table 6.6: Forecasted Annual Revenue-RNA Sample Preparation, 2005-201025

Table 6.7: Projected Revenue Growth of Microarrays and Related Products26

Table 6.8: Major Players' Distribution of Revenue by Region, 200527

Table 6.9: Decision Makers Profile31

Table 9.1: Major Vendors-Gene Expression Reagents and RNA Sample Preparation35

Table 9.2: Vendors' Key Statistics, 200536

Table 9.3: Vendors' Technology and Products36

Table 11.1: RNA Sample Preparation-Vendors Prices40

Table 11.2: qPCR Kits-Vendor's Prices41

Table 11.3: Reverse Transcriptase-Vendor's Prices42

Table 12.1: Distribution Channels43

Table 15.1: Applied Biosystems Revenue, 200548

Table 15.2: Affymetrix Revenue, 200553

Table 15.3: Invitrogen Revenue, 200559

Table 15.4: Qiagen Revenue, 200567

Table 15.5: GE Healthcare Revenue, 200572

Table 15.6: Stratagene Revenue, 200577

Other users found this report page using the following search terms: gene expression pcr taqman gene reagents director marketing expression healthcare ge global revenue24 microarray

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.